Medical Marijuana, Inc. subsidiary HempMeds® Brasil to participate in innovative cannabis seminar in Brazil.
Medical Marijuana, Inc. portfolio company HempMeds® Brasil is a sponsor for the upcoming “A Look Into the Future” International Medicinal Seminar being held this weekend in Brazil.
Scheduled for May 18-19 in Rio de Janeiro, Brazil, the event intends to explore more closely the potential of cannabis products like CBD oil from RSHO™ in healthcare. The event will cover efforts for expanded access, results of cannabis research, the current regulation of cannabis in Brazil, and the impact medical cannabis can play in public health.
Speakers and participants at the event include the CEO of ANVISA, Brazil’s health authority, experts on cancer, autism, and neurological diseases, and cannabis researchers. An international event, doctors from Australia, Canada, Holland, Chile, and Colombia will be sharing their experiences with medical cannabis, including CBD.
“Our Company is proud to sponsor such a prestigious seminar,” said HempMeds® Brasil Vice President Caroline Heinz. “We hope that the manifesto being presented at the event will present itself as a call-to-action for the country’s authorities to help us create a safe and legal cannabis market.”
The event will be held at the Museum of Tomorrow, chosen for its symbolic significance as the seminar is intended to discuss the future of medical cannabis in Brazil.
Along with being a main sponsor for the event, HempMeds® Brasil will host a booth at the event where patients, doctors and health professionals, business owners, and other attendees can stop by to learn more about the company, the RSHO™ line of CBD oil products, and the promise CBD holds as a therapeutic compound in Brazil.
Participation in the “A Look Into the Future” International Medicinal Seminar is one more step towards Medical Marijuana, Inc.’s goal of access to CBD for everyone, regardless of where they live.
“Our international presence is important to the future of the company because we want to show that we care about access to CBD around the world, not just in the U.S.,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
In April of 2014, HempMeds® became the first company to legally distribute CBD products in Brazil through HempMeds® Brasil. HempMeds® Brasil has been instrumental in creating access to medical cannabis in Brazil, a country of over 200 million people and the world’s ninth largest economy. HempMeds® Brasil assists local patients in purchasing and obtaining permission from the government to import RSHO™, even helping patients secure reimbursement from the government for their medication.
HempMeds® also helped to open a number of other markets to CBD, including Puerto Rico, Mexico, Paraguay, and more. Most recently, the company began distributing RSHO™ CBD products through a pharmacy in Bermuda.
Learn More About HempMeds® Brasil
You can find additional information about HempMeds® Brasil, the company’s efforts to increase access to CBD products in Brazil, and other developments from the Medical Marijuana, Inc. family of companies on our news feed.
Patients and doctors in Brazil hoping to learn more about the process for accessing CBD can visit the HempMeds® Brasil website here.